|
| | 104TH GENERAL ASSEMBLY
State of Illinois
2025 and 2026 HB5225 Introduced 2/10/2026, by Rep. Natalie A. Manley SYNOPSIS AS INTRODUCED: | | 215 ILCS 5/356z.14 | | 225 ILCS 110/3 | from Ch. 111, par. 7903 | 225 ILCS 110/8.4 new | | 305 ILCS 5/5-30.11 | |
| Amends the Illinois Speech-Language Pathology and Audiology Practice Act. Allows a speech-language pathologist to diagnose autism spectrum disorders if: (1) the child is under 3 years of age; and (2) the speech-language pathologist is trained in autism diagnostic evaluation methods as part of the curriculum of an approved program, through worksite training, or through continuing education. Provides that if a diagnosis requires a plan of care that includes elements that are outside the scope of practice of a speech-language pathologist, the speech-language pathologist must refer the patient to the appropriate medical personnel for further evaluation or management. Makes conforming changes in the Medical Assistance Article of the Illinois Public Aid Code, and provisions of the Illinois Insurance Code concerning autism spectrum disorders. Effective July 1, 2027. |
| |
| | A BILL FOR |
|
|
| | HB5225 | | LRB104 20453 AAS 33918 b |
|
|
| 1 | | AN ACT concerning regulation. |
| 2 | | Be it enacted by the People of the State of Illinois, |
| 3 | | represented in the General Assembly: |
| 4 | | Section 5. The Illinois Insurance Code is amended by |
| 5 | | changing Section 356z.14 as follows: |
| 6 | | (215 ILCS 5/356z.14) |
| 7 | | Sec. 356z.14. Autism spectrum disorders. |
| 8 | | (a) A group or individual policy of accident and health |
| 9 | | insurance or managed care plan amended, delivered, issued, or |
| 10 | | renewed after December 12, 2008 (the effective date of Public |
| 11 | | Act 95-1005) must provide individuals under 21 years of age |
| 12 | | coverage for the diagnosis of autism spectrum disorders and |
| 13 | | for the treatment of autism spectrum disorders to the extent |
| 14 | | that the diagnosis and treatment of autism spectrum disorders |
| 15 | | are not already covered by the policy of accident and health |
| 16 | | insurance or managed care plan. |
| 17 | | (b) Coverage provided under this Section shall be subject |
| 18 | | to a maximum benefit of $36,000 per year but shall not be |
| 19 | | subject to any limits on the number of visits to a service |
| 20 | | provider. The Director of Insurance shall, on an annual basis, |
| 21 | | adjust the maximum benefit for inflation using the Medical |
| 22 | | Care Component of the United States Department of Labor |
| 23 | | Consumer Price Index for All Urban Consumers. Payments made by |
|
| | HB5225 | - 2 - | LRB104 20453 AAS 33918 b |
|
|
| 1 | | an insurer on behalf of a covered individual for any care, |
| 2 | | treatment, intervention, service, or item, the provision of |
| 3 | | which was for the treatment of a health condition not |
| 4 | | diagnosed as an autism spectrum disorder, shall not be applied |
| 5 | | toward any maximum benefit established under this subsection. |
| 6 | | (c) Coverage under this Section shall be subject to |
| 7 | | copayment, deductible, and coinsurance provisions of a policy |
| 8 | | of accident and health insurance or managed care plan to the |
| 9 | | extent that other medical services covered by the policy of |
| 10 | | accident and health insurance or managed care plan are subject |
| 11 | | to these provisions. |
| 12 | | (d) This Section shall not be construed as limiting |
| 13 | | benefits that are otherwise available to an individual under a |
| 14 | | policy of accident and health insurance or managed care plan |
| 15 | | and benefits provided under this Section may not be subject to |
| 16 | | dollar limits, deductibles, copayments, or coinsurance |
| 17 | | provisions that are less favorable to the insured than the |
| 18 | | dollar limits, deductibles, or coinsurance provisions that |
| 19 | | apply to physical illness generally. |
| 20 | | (e) An insurer may not deny or refuse to provide otherwise |
| 21 | | covered services, or refuse to renew, refuse to reissue, or |
| 22 | | otherwise terminate or restrict coverage under an individual |
| 23 | | contract to provide services to an individual because the |
| 24 | | individual or the individual's dependent is diagnosed with an |
| 25 | | autism spectrum disorder or due to the individual utilizing |
| 26 | | benefits in this Section. |
|
| | HB5225 | - 3 - | LRB104 20453 AAS 33918 b |
|
|
| 1 | | (e-5) An insurer may not deny or refuse to provide |
| 2 | | otherwise covered services under a group or individual policy |
| 3 | | of accident and health insurance or a managed care plan solely |
| 4 | | because of the location wherein the clinically appropriate |
| 5 | | services are provided. |
| 6 | | (f) Upon request of the insurer, a provider of treatment |
| 7 | | for autism spectrum disorders shall furnish medical records, |
| 8 | | clinical notes, or other necessary data that substantiate that |
| 9 | | initial or continued medical treatment is medically necessary |
| 10 | | and is resulting in improved clinical status. When treatment |
| 11 | | is anticipated to require continued services to achieve |
| 12 | | demonstrable progress, the insurer may request a treatment |
| 13 | | plan consisting of diagnosis, proposed treatment by type, |
| 14 | | frequency, anticipated duration of treatment, the anticipated |
| 15 | | outcomes stated as goals, and the frequency by which the |
| 16 | | treatment plan will be updated. Nothing in this subsection |
| 17 | | supersedes the prohibition on prior authorization for mental |
| 18 | | health treatment under subsection (w) of Section 370c. |
| 19 | | (g) When making a determination of medical necessity for a |
| 20 | | treatment modality for autism spectrum disorders, an insurer |
| 21 | | must make the determination in a manner that is consistent |
| 22 | | with the manner used to make that determination with respect |
| 23 | | to other diseases or illnesses covered under the policy, |
| 24 | | including an appeals process. During the appeals process, any |
| 25 | | challenge to medical necessity must be viewed as reasonable |
| 26 | | only if the review includes a physician with expertise in the |
|
| | HB5225 | - 4 - | LRB104 20453 AAS 33918 b |
|
|
| 1 | | most current and effective treatment modalities for autism |
| 2 | | spectrum disorders. |
| 3 | | (h) Coverage for medically necessary early intervention |
| 4 | | services must be delivered by certified early intervention |
| 5 | | specialists, as defined in 89 Ill. Adm. Code 500 and any |
| 6 | | subsequent amendments thereto. |
| 7 | | (h-5) If an individual has been diagnosed as having an |
| 8 | | autism spectrum disorder, meeting the diagnostic criteria in |
| 9 | | place at the time of diagnosis, and treatment is determined |
| 10 | | medically necessary, then that individual shall remain |
| 11 | | eligible for coverage under this Section even if subsequent |
| 12 | | changes to the diagnostic criteria are adopted by the American |
| 13 | | Psychiatric Association. If no changes to the diagnostic |
| 14 | | criteria are adopted after April 1, 2012, and before December |
| 15 | | 31, 2014, then this subsection (h-5) shall be of no further |
| 16 | | force and effect. |
| 17 | | (h-10) An insurer may not deny or refuse to provide |
| 18 | | covered services, or refuse to renew, refuse to reissue, or |
| 19 | | otherwise terminate or restrict coverage under an individual |
| 20 | | contract, for a person diagnosed with an autism spectrum |
| 21 | | disorder on the basis that the individual declined an |
| 22 | | alternative medication or covered service when the |
| 23 | | individual's health care provider has determined that such |
| 24 | | medication or covered service may exacerbate clinical |
| 25 | | symptomatology and is medically contraindicated for the |
| 26 | | individual and the individual has requested and received a |
|
| | HB5225 | - 5 - | LRB104 20453 AAS 33918 b |
|
|
| 1 | | medical exception as provided for under Section 45.1 of the |
| 2 | | Managed Care Reform and Patient Rights Act. For the purposes |
| 3 | | of this subsection (h-10), "clinical symptomatology" means any |
| 4 | | indication of disorder or disease when experienced by an |
| 5 | | individual as a change from normal function, sensation, or |
| 6 | | appearance. |
| 7 | | (h-15) If, at any time, the Secretary of the United States |
| 8 | | Department of Health and Human Services, or its successor |
| 9 | | agency, promulgates rules or regulations to be published in |
| 10 | | the Federal Register or publishes a comment in the Federal |
| 11 | | Register or issues an opinion, guidance, or other action that |
| 12 | | would require the State, pursuant to any provision of the |
| 13 | | Patient Protection and Affordable Care Act (Public Law |
| 14 | | 111-148), including, but not limited to, 42 U.S.C. |
| 15 | | 18031(d)(3)(B) or any successor provision, to defray the cost |
| 16 | | of any coverage outlined in subsection (h-10), then subsection |
| 17 | | (h-10) is inoperative with respect to all coverage outlined in |
| 18 | | subsection (h-10) other than that authorized under Section |
| 19 | | 1902 of the Social Security Act, 42 U.S.C. 1396a, and the State |
| 20 | | shall not assume any obligation for the cost of the coverage |
| 21 | | set forth in subsection (h-10). |
| 22 | | (i) As used in this Section: |
| 23 | | "Autism spectrum disorders" means pervasive developmental |
| 24 | | disorders as defined in the most recent edition of the |
| 25 | | Diagnostic and Statistical Manual of Mental Disorders, |
| 26 | | including autism, Asperger's disorder, and pervasive |
|
| | HB5225 | - 6 - | LRB104 20453 AAS 33918 b |
|
|
| 1 | | developmental disorder not otherwise specified. |
| 2 | | "Diagnosis of autism spectrum disorders" means one or more |
| 3 | | tests, evaluations, or assessments to diagnose whether an |
| 4 | | individual has autism spectrum disorder that is prescribed, |
| 5 | | performed, or ordered by (A) a physician licensed to practice |
| 6 | | medicine in all its branches, or (B) a licensed clinical |
| 7 | | psychologist with expertise in diagnosing autism spectrum |
| 8 | | disorders, or (C) a licensed speech-language pathologist with |
| 9 | | expertise in diagnosing autism spectrum disorders. |
| 10 | | "Medically necessary" means any care, treatment, |
| 11 | | intervention, service, or item which will or is reasonably |
| 12 | | expected to do any of the following: (i) prevent the onset of |
| 13 | | an illness, condition, injury, disease, or disability; (ii) |
| 14 | | reduce or ameliorate the physical, mental, or developmental |
| 15 | | effects of an illness, condition, injury, disease, or |
| 16 | | disability; or (iii) assist to achieve or maintain maximum |
| 17 | | functional activity in performing daily activities. |
| 18 | | "Treatment for autism spectrum disorders" shall include |
| 19 | | the following care prescribed, provided, or ordered for an |
| 20 | | individual diagnosed with an autism spectrum disorder by (A) a |
| 21 | | physician licensed to practice medicine in all its branches or |
| 22 | | (B) a certified, registered, or licensed health care |
| 23 | | professional with expertise in treating effects of autism |
| 24 | | spectrum disorders when the care is determined to be medically |
| 25 | | necessary and ordered by a physician licensed to practice |
| 26 | | medicine in all its branches: |
|
| | HB5225 | - 7 - | LRB104 20453 AAS 33918 b |
|
|
| 1 | | (1) Psychiatric care, meaning direct, consultative, or |
| 2 | | diagnostic services provided by a licensed psychiatrist. |
| 3 | | (2) Psychological care, meaning direct or consultative |
| 4 | | services provided by a licensed psychologist. |
| 5 | | (3) Habilitative or rehabilitative care, meaning |
| 6 | | professional, counseling, and guidance services and |
| 7 | | treatment programs, including applied behavior analysis, |
| 8 | | that are intended to develop, maintain, and restore the |
| 9 | | functioning of an individual. As used in this subsection |
| 10 | | (i), "applied behavior analysis" means the design, |
| 11 | | implementation, and evaluation of environmental |
| 12 | | modifications using behavioral stimuli and consequences to |
| 13 | | produce socially significant improvement in human |
| 14 | | behavior, including the use of direct observation, |
| 15 | | measurement, and functional analysis of the relations |
| 16 | | between environment and behavior. |
| 17 | | (4) Therapeutic care, including behavioral, speech, |
| 18 | | occupational, and physical therapies that provide |
| 19 | | treatment in the following areas: (i) self care and |
| 20 | | feeding, (ii) pragmatic, receptive, and expressive |
| 21 | | language, (iii) cognitive functioning, (iv) applied |
| 22 | | behavior analysis, intervention, and modification, (v) |
| 23 | | motor planning, and (vi) sensory processing. |
| 24 | | (j) Rulemaking authority to implement this amendatory Act |
| 25 | | of the 95th General Assembly, if any, is conditioned on the |
| 26 | | rules being adopted in accordance with all provisions of the |
|
| | HB5225 | - 8 - | LRB104 20453 AAS 33918 b |
|
|
| 1 | | Illinois Administrative Procedure Act and all rules and |
| 2 | | procedures of the Joint Committee on Administrative Rules; any |
| 3 | | purported rule not so adopted, for whatever reason, is |
| 4 | | unauthorized. |
| 5 | | (Source: P.A. 103-154, eff. 6-30-23; 104-28, eff. 1-1-26; |
| 6 | | 104-417, eff. 8-15-25.) |
| 7 | | Section 10. The Illinois Speech-Language Pathology and |
| 8 | | Audiology Practice Act is amended by changing Section 3 and by |
| 9 | | adding Section 8.4 as follows: |
| 10 | | (225 ILCS 110/3) (from Ch. 111, par. 7903) |
| 11 | | (Section scheduled to be repealed on January 1, 2028) |
| 12 | | Sec. 3. Definitions. The following words and phrases shall |
| 13 | | have the meaning ascribed to them in this Section unless the |
| 14 | | context clearly indicates otherwise: |
| 15 | | (a) "Department" means the Department of Financial and |
| 16 | | Professional Regulation. |
| 17 | | (b) "Secretary" means the Secretary of Financial and |
| 18 | | Professional Regulation. |
| 19 | | (c) "Board" means the Board of Speech-Language Pathology |
| 20 | | and Audiology established under Section 5 of this Act. |
| 21 | | (d) "Speech-Language Pathologist" means a person who has |
| 22 | | received a license pursuant to this Act and who engages in the |
| 23 | | practice of speech-language pathology. |
| 24 | | (e) "Audiologist" means a person who has received a |
|
| | HB5225 | - 9 - | LRB104 20453 AAS 33918 b |
|
|
| 1 | | license pursuant to this Act and who engages in the practice of |
| 2 | | audiology. |
| 3 | | (f) "Public member" means a person who is not a health |
| 4 | | professional. For purposes of board membership, any person |
| 5 | | with a significant financial interest in a health service or |
| 6 | | profession is not a public member. |
| 7 | | (g) "The practice of audiology" is the application of |
| 8 | | nonsurgical methods and procedures for the screening, |
| 9 | | identification, measurement, monitoring, testing, appraisal, |
| 10 | | prediction, interpretation, habilitation, rehabilitation, or |
| 11 | | instruction related to audiologic or vestibular disorders, |
| 12 | | including hearing and disorders of hearing. These procedures |
| 13 | | are for the purpose of counseling, consulting and rendering or |
| 14 | | offering to render services or for participating in the |
| 15 | | planning, directing or conducting of programs that are |
| 16 | | designed to modify communicative disorders involving speech, |
| 17 | | language, auditory, or vestibular function related to hearing |
| 18 | | loss. The practice of audiology may include, but shall not be |
| 19 | | limited to, the following: |
| 20 | | (1) any task, procedure, act, or practice that is |
| 21 | | necessary for the evaluation and management of audiologic, |
| 22 | | hearing, or vestibular function, including, but not |
| 23 | | limited to, neurophysiologic intraoperative monitoring of |
| 24 | | the seventh or eighth cranial nerve function; |
| 25 | | (2) training in the use of amplification devices; |
| 26 | | (3) the evaluation, fitting, dispensing, or servicing |
|
| | HB5225 | - 10 - | LRB104 20453 AAS 33918 b |
|
|
| 1 | | of hearing instruments and auditory prosthetic devices, |
| 2 | | such as cochlear implants, auditory osseointegrated |
| 3 | | devices, and brainstem implants; |
| 4 | | (4) cerumen removal; |
| 5 | | (5) performing basic speech and language screening |
| 6 | | tests and procedures consistent with audiology training; |
| 7 | | and |
| 8 | | (6) performing basic health screenings in accordance |
| 9 | | with Section 8.3 of this Act. |
| 10 | | (h) "The practice of speech-language pathology" is the |
| 11 | | application of nonmedical methods and procedures for the |
| 12 | | identification, measurement, testing, appraisal, prediction, |
| 13 | | habilitation, rehabilitation, and modification related to |
| 14 | | communication development, and disorders or disabilities of |
| 15 | | speech, language, voice, swallowing, and other speech, |
| 16 | | language and voice related disorders. These procedures are for |
| 17 | | the purpose of counseling, consulting and rendering or |
| 18 | | offering to render services, or for participating in the |
| 19 | | planning, directing or conducting of programs that are |
| 20 | | designed to modify communicative disorders and conditions in |
| 21 | | individuals or groups of individuals involving speech, |
| 22 | | language, voice and swallowing function. |
| 23 | | "The practice of speech-language pathology" shall include, |
| 24 | | but shall not be limited to, the following: |
| 25 | | (1) hearing screening tests and aural rehabilitation |
| 26 | | procedures consistent with speech-language pathology |
|
| | HB5225 | - 11 - | LRB104 20453 AAS 33918 b |
|
|
| 1 | | training; |
| 2 | | (2) tasks, procedures, acts or practices that are |
| 3 | | necessary for the evaluation of, and training in the use |
| 4 | | of, augmentative communication systems, communication |
| 5 | | variation, cognitive rehabilitation, non-spoken language |
| 6 | | production and comprehension; |
| 7 | | (3) the use of rigid or flexible laryngoscopes for the |
| 8 | | sole purpose of observing and obtaining images of the |
| 9 | | pharynx and larynx in accordance with Section 9.3 of this |
| 10 | | Act; and |
| 11 | | (4) performing basic health screenings in accordance |
| 12 | | with Section 8.3 of this Act; and . |
| 13 | | (5) diagnosing autism spectrum disorders in accordance |
| 14 | | with Section 8.4 of this Act. |
| 15 | | (i) "Speech-language pathology assistant" means a person |
| 16 | | who has received a license pursuant to this Act to assist a |
| 17 | | speech-language pathologist in the manner provided in this |
| 18 | | Act. |
| 19 | | (j) "Physician" means a physician licensed to practice |
| 20 | | medicine in all its branches under the Medical Practice Act of |
| 21 | | 1987. |
| 22 | | (k) "Email address of record" means the designated email |
| 23 | | address recorded by the Department in the applicant's |
| 24 | | application file or the licensee's license file, as maintained |
| 25 | | by the Department's licensure maintenance unit. |
| 26 | | (l) "Address of record" means the designated address |
|
| | HB5225 | - 12 - | LRB104 20453 AAS 33918 b |
|
|
| 1 | | recorded by the Department in the applicant's or licensee's |
| 2 | | application file or license file as maintained by the |
| 3 | | Department's licensure maintenance unit. |
| 4 | | (m) "Neurophysiologic intraoperative monitoring" means the |
| 5 | | process of continual testing and interpretation of test |
| 6 | | results using electrodiagnostic modalities to monitor the |
| 7 | | seventh and eighth cranial nerve function during a surgical |
| 8 | | procedure. Neurophysiologic intraoperative monitoring does not |
| 9 | | include testing and interpretation of test results using |
| 10 | | electrodiagnostic modalities to monitor the spinal cord, |
| 11 | | peripheral nerves (other than the seventh and eighth cranial |
| 12 | | nerve), cerebral hemispheres, or brainstem. Neurophysiologic |
| 13 | | intraoperative monitoring may be performed by an audiologist |
| 14 | | only if authorized by the physician performing the surgical |
| 15 | | procedure. |
| 16 | | (Source: P.A. 100-530, eff. 1-1-18.) |
| 17 | | (225 ILCS 110/8.4 new) |
| 18 | | Sec. 8.4. Diagnosing autism spectrum disorders. A |
| 19 | | speech-language pathologist may diagnose autism spectrum |
| 20 | | disorders if: |
| 21 | | (1) the child is under 3 years of age; and |
| 22 | | (2) the speech-language pathologist is trained in |
| 23 | | autism diagnostic evaluation methods: |
| 24 | | (A) as part of the curriculum of an approved |
| 25 | | program; |
|
| | HB5225 | - 13 - | LRB104 20453 AAS 33918 b |
|
|
| 1 | | (B) through worksite training; or |
| 2 | | (C) through continuing education. |
| 3 | | If a diagnosis requires a plan of care that includes |
| 4 | | elements that are outside the scope of practice of a |
| 5 | | speech-language pathologist, the speech-language pathologist |
| 6 | | must refer the patient to the appropriate medical personnel |
| 7 | | for further evaluation or management. |
| 8 | | Section 15. The Illinois Public Aid Code is amended by |
| 9 | | changing Section 5-30.11 as follows: |
| 10 | | (305 ILCS 5/5-30.11) |
| 11 | | Sec. 5-30.11. Treatment of autism spectrum disorder. |
| 12 | | Treatment of autism spectrum disorder through applied behavior |
| 13 | | analysis shall be covered under the medical assistance program |
| 14 | | under this Article for children with a diagnosis of autism |
| 15 | | spectrum disorder when (1) ordered by a physician licensed to |
| 16 | | practice medicine in all its branches, or a psychologist |
| 17 | | licensed by the Department of Financial and Professional |
| 18 | | Regulation, or a speech-language pathologist licensed by the |
| 19 | | Department of Financial and Professional Regulation and (2) |
| 20 | | evaluated by a behavior analyst as recognized by the |
| 21 | | Department or licensed by the Department of Financial and |
| 22 | | Professional Regulation to practice applied behavior analysis |
| 23 | | in this State. Such coverage may be limited to age ranges based |
| 24 | | on evidence-based best practices. Appropriate State plan |
|
| | HB5225 | - 14 - | LRB104 20453 AAS 33918 b |
|
|
| 1 | | amendments as well as rules regarding provision of services |
| 2 | | and providers will be submitted by September 1, 2019. Pursuant |
| 3 | | to the flexibilities allowed by the federal Centers for |
| 4 | | Medicare and Medicaid Services to Illinois under the Medical |
| 5 | | Assistance Program, the Department shall enroll and reimburse |
| 6 | | qualified staff to perform applied behavior analysis services |
| 7 | | in advance of Illinois licensure activities performed by the |
| 8 | | Department of Financial and Professional Regulation. These |
| 9 | | services shall be covered if they are provided in a home or |
| 10 | | community setting or in an office-based setting. The |
| 11 | | Department may conduct annual on-site reviews of the services |
| 12 | | authorized under this Section. Provider enrollment shall occur |
| 13 | | no later than September 1, 2023. |
| 14 | | (Source: P.A. 102-558, eff. 8-20-21; 102-953, eff. 5-27-22; |
| 15 | | 103-102, eff. 7-1-23.) |
| 16 | | Section 99. Effective date. This Act takes effect July 1, |
| 17 | | 2027. |